Presumptive Service Connection for Diseases Associated With Persian Gulf War Service: Functional Gastrointestinal Disorders, 70162-70165 [2010-28707]
Download as PDF
erowe on DSK5CLS3C1PROD with PROPOSALS-1
70162
Federal Register / Vol. 75, No. 221 / Wednesday, November 17, 2010 / Proposed Rules
requirements of the Federal external
review process established under
section 2719 of the PHS Act and its
implementing regulations. In such a
case, the contractor would be
responsible for conducting standard and
expedited reviews of all adverse benefit
determinations and final internal
adverse benefit determinations that are
eligible for external review as defined
by the regulations. Reviews would be
conducted in an accurate, efficient,
timely, and consistent manner. In
conjunction with completing these
reviews, the contractor may be tasked
with the following functions and
responsibilities to support the
permanent Federal external appeals
process:
• Development, maintenance,
distribution, and update of ‘‘decision
support’’ protocols;
• Adjudication of external review
cases, using established protocols;
• Timely and accurate disposition of
all external review cases;
• Collection, consolidation, storage,
maintenance, and transmission of
information regarding the receipt and
disposition of external review cases for
the Federal external review process;
• Performance of statistical and data
analyses of external review cases to
include trend analyses, and compliance
with HHS data and reporting
requirements including ad-hoc analyses
for reports and inquiries from HHS,
Congress, and other entities, and for
purposes of continuous quality
improvement;
• Participation and coordination with
other entities (including other IROs)
involved in the Federal external review
process for quality improvement
purposes;
• Communication of external review
decisions to claimants and other parties
involved in the case;
• Case management and
documentation, which may include
document imaging to produce a
complete electronic case file; and
• Training all critical and qualified
staff on all aspects of the external
review process.
Accordingly, the Departments of HHS
and Labor are seeking to engage
formally, in a transparent and
participatory manner, with the public
on best practices and standards
currently used by IROs. Specific
questions are set forth below. Comments
are invited from all stakeholders on
these issues.
Qualified Organizations and Staff
(1) What accreditation standards
currently apply to IROs?
VerDate Mar<15>2010
15:18 Nov 16, 2010
Jkt 223001
(2) What credentialing standards do
IROs require for medical and legal
reviewers? Is credentialing required or
voluntary?
(3) What procedures are currently
used by IROs to assure that reviewers do
not have conflicts of interest with
disputing parties?
(4) What are IROs’ current capacity for
performing reviews? Does staffing and
the time necessary for performing a
review differ based on the type of claim
(e.g., medical necessity, experimental/
investigational treatment, coverage
issues, etc.)?
Infrastructure
(5) Please describe the type of data
collection systems that IROs currently
use to conduct analyses, reporting, and
tracking of appeals and grievances.
(6) Are the current data systems
available in a secure, 508-compliant,
web-based interactive structure?
(7) What telecommunication systems
and consumer technical support
systems do IROs currently maintain for
consumers (e.g., Web sites, 24-hour
hotlines, helpdesk, and/or translation
services for non-English speakers)?
(8) What is a reasonable amount of
time for a contractor to become fully
operational (have all systems in place to
conduct external reviews) after the date
of a contract award? What resources
would be necessary?
(9) What considerations must be taken
into account to smoothly transition from
the current Federal interim external
review process to a possible new
permanent Federal external review
process?
(10) Do IROs currently operate
nationally or in limited geographic
areas? Would IROs that currently serve
local areas be able to expand their
service areas to possibly include other
geographic areas such as other States?
Are there any State and/or local
licensing requirements?
(11) Are there any special
considerations HHS and/or DOL should
be aware of in considering a specialized
contract for urgent care appeals or for
experimental and investigational
treatments? Would such an approach
have an impact on coordination?
(12) Please describe the difference in
standard operating procedures and
resources (time, cost, personnel) for
appeals that involve only medical
necessity and those that involve both
medical necessity and coverage
questions.
Data Collection
(13) What data are currently collected
by IROs for tracking appeals and
conducting analyses?
PO 00000
Frm 00013
Fmt 4702
Sfmt 4702
(14) What steps are taken to ensure
confidentiality and security protections
of patient information?
Evaluation
(15) Do IROs (or subcontractors)
currently conduct evaluations of their
operations? Do such evaluations include
an assessment of how easy it is for
consumers to access and use the
external review process in a timely
manner? Do evaluations result in quality
improvement initiatives? If so, what are
some examples of quality improvement
initiatives undertaken by IROs?
(16) What specific requirements
should be applied to IROs to evaluate
progress toward performance goals?
What performance goals are the most
appropriate?
Signed at Washington, DC, November 10,
2010.
Elizabeth Fowler,
Director of Policy, Office of Consumer
Information and Insurance Oversight.
Department of Health and Human Services.
Signed at Washington, DC, November 9,
2010.
Phyllis C. Borzi,
Assistant Secretary, Employee Benefits
Security Administration Department of Labor.
[FR Doc. 2010–28876 Filed 11–12–10; 11:15 am]
BILLING CODE 4150–29– 4150–65–P
DEPARTMENT OF VETERANS
AFFAIRS
38 CFR Part 3
RIN 2900–AN83
Presumptive Service Connection for
Diseases Associated With Persian Gulf
War Service: Functional
Gastrointestinal Disorders
Department of Veterans Affairs.
Proposed rule.
AGENCY:
ACTION:
The Department of Veterans
Affairs (VA) is amending its
adjudication regulations concerning
presumptive service connection for
medically unexplained chronic
multisymptom illnesses associated with
service in the Southwest Asia theater of
operations for which there is no record
during service. This amendment is
necessary to implement a decision of
the Secretary of Veterans Affairs that
there is a positive association between
service in Southwest Asia during certain
periods and the subsequent
development of functional
gastrointestinal disorders (FGIDs), and
to clarify that FGIDs fall within the
scope of the existing presumption of
service connection for medically
SUMMARY:
E:\FR\FM\17NOP1.SGM
17NOP1
erowe on DSK5CLS3C1PROD with PROPOSALS-1
Federal Register / Vol. 75, No. 221 / Wednesday, November 17, 2010 / Proposed Rules
unexplained chronic multisymptom
illnesses. The intended effect of this
amendment is to clarify the
presumption of service connection for
these illnesses based on service in the
Southwest Asia theater of operations
during the Persian Gulf War.
DATES: Comments must be received by
VA on or before December 17, 2010.
ADDRESSES: Written comments may be
submitted through https://
www.Regulations.gov; by mail or handdelivery to Director, Regulations
Management (02REG), Department of
Veterans Affairs, 810 Vermont Ave.,
NW., Room 1068, Washington, DC
20420; or by fax to (202) 273–9026.
(This is not a toll free number.)
Comments should indicate that they are
submitted in response to ‘‘RIN 2900–
AN83—Presumptive Service Connection
for Diseases Associated With Persian
Gulf War Service: Functional
Gastrointestinal Disorders (FGIDs).’’
Copies of comments received will be
available for public inspection in the
Office of Regulation Policy and
Management, Room 1063B, between the
hours of 8 a.m. and 4:30 p.m., Monday
through Friday (except holidays). Please
call (202) 461–4902 for an appointment.
(This is not a toll free number.) In
addition, during the comment period,
comments may be viewed online
through the Federal Docket Management
System at https://www.Regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Gerald Johnson, Regulations Staff
(211D), Compensation and Pension
Service, Veterans Benefits
Administration, Department of Veterans
Affairs, 810 Vermont Avenue, NW.,
Washington, DC 20420, (202) 461- 9727
(This is not a toll-free number.)
SUPPLEMENTARY INFORMATION: The
Secretary of Veterans Affairs has
determined that the available scientific
and medical evidence presented in the
National Academy of Sciences (NAS)
April 2010 report, titled Gulf War and
Health, Volume 8: Update on the Health
Effects of Serving in the Gulf War is
sufficient to warrant a presumption of
service connection for FGIDs in
individuals deployed to the Southwest
Asia theater of operations during the
Persian Gulf War. Pursuant to that
determination, this document proposes
to clarify that the Department of
Veterans Affairs (VA) adjudication
regulations (38 CFR Part 3), specifically
38 CFR 3.317, would include FGIDs as
medically unexplained chronic
multisymptom illnesses subject to
presumptive service connection. FGIDs
include, but are not limited to, such
conditions as irritable bowel syndrome
(IBS) and functional dyspepsia.
VerDate Mar<15>2010
15:18 Nov 16, 2010
Jkt 223001
National Academy of Sciences (NAS)
Reports
FGIDs, Including, But Not Limited to,
Irritable Bowel Syndrome (IBS) and
Functional Dyspepsia
The NAS issued its report titled Gulf
War and Health, Volume 8: Update on
Health Effects of Serving in the Gulf
War, on April 9, 2010. The NAS was
asked to review, evaluate, and
summarize the literature to determine if
any of the health outcomes noted in its
2006 report, titled Gulf War and Health,
Volume 4: Health Effects of Serving in
the Gulf War, appear at higher incidence
or prevalence levels in Gulf Wardeployed veterans. The NAS sought to
characterize and weigh the strengths
and limitations of the available
evidence. The NAS Update committee
reviewed over 1000 relevant studies and
focused on over 400 relevant references,
including the studies reviewed in the
Volume 4 report. The NAS determined
that there is sufficient evidence of an
association between deployment to the
Gulf War and FGIDs, including, but not
limited to, IBS and functional
dyspepsia. The committee also noted
that there is inadequate evidence of an
association between deployment to the
Gulf War and structural gastrointestinal
(GI) disease.
FGIDs, such as IBS or functional
dyspepsia, are syndromes characterized
by recurrent or prolonged GI symptoms
that occur together. They are
distinguished from structural or
‘‘organic’’ GI disorders in that they
generally are not associated with
detectable anatomical abnormalities.
The severity of FGIDs ranges from
occasional mild episodes to more
persistent and disabling symptoms.
According to the NAS report, there have
been numerous reports of GI
disturbances in Gulf War veterans and
the symptoms have continued to be
persistent in the years since that war.
All studies examined by NAS favored a
greater prevalence of various GI
symptoms and primary functional GI
disorders, including IBS and dyspepsia.
In NAS’s opinion, there also was
compelling emerging evidence of
exposure during deployment to enteric
pathogens leading to the development of
post-infectious IBS.
The overall pattern of symptoms
found in the primary and secondary
studies NAS reviewed confirms an
association between deployment to the
Gulf War and functional GI symptoms,
including abdominal pain, diarrhea,
nausea, and vomiting. The NAS
recommended that further studies be
conducted to determine the role of prior
acute gastroenteritis among deployed
PO 00000
Frm 00014
Fmt 4702
Sfmt 4702
70163
servicemembers in the development of
FGIDs.
Detailed information on the
committee’s findings may be found at:
https://www.iom.edu/Reports/2010/GulfWar-and-Health-Volume-8–HealthEffects-of-Serving-in-the-Gulf-War.aspx.
The report findings are organized by
category and can be found under the
heading, ‘‘Table of Contents.’’
Statutory Provisions
Pursuant to 38 U.S.C. 1118, VA must
establish a presumption of service
connection for each illness shown by
sound scientific and medical evidence
to have a positive association with
exposure to a biological, chemical, or
other toxic agent, environmental or
wartime hazard, or preventive medicine
or vaccine known or presumed to be
associated with service in the Armed
Forces in the Southwest Asia theater of
operations during the Persian Gulf War.
Because the recent NAS report was
primarily a review of the prevalence of
illnesses among Gulf War veterans, it
generally did not state conclusions as to
whether the illnesses are associated
with the types of exposures referenced
in § 1118. The NAS noted that there was
significant emerging evidence that
FGIDs may be associated with exposure
to enteric pathogens during Gulf War
deployments and recommended further
study of that issue. However, NAS did
not state a conclusion concerning the
strength of the evidence of an
association between FGIDs and
exposure to enteric pathogens. VA has
determined that resolution of that
question is not necessary for purposes of
this rule, because FGIDs are within the
scope of the existing presumption of
service connection for medically
unexplained chronic multisymptom
illnesses.
Section 1117 of title 38, United States
Code, provides a presumption of service
connection for ‘‘qualifying chronic
disability’’ in veterans who served in the
Southwest Asia theater of operations
during the Persian Gulf War. The statute
defines the term ‘‘qualifying chronic
disability’’ to include ‘‘[a] medically
unexplained chronic multisymptom
illness (such as chronic fatigue
syndrome, fibromyalgia, and irritable
bowel syndrome) that is defined by a
cluster of signs or symptoms.’’ 38 U.S.C.
1117(a)(2)(B). The plain language of the
statute makes clear that it applies to all
medically unexplained chronic
multisymptom illnesses including, but
not limited to, the three conditions
parenthetically listed as examples. VA
recently amended its regulation at 38
CFR 3.317 to clarify that the
E:\FR\FM\17NOP1.SGM
17NOP1
70164
Federal Register / Vol. 75, No. 221 / Wednesday, November 17, 2010 / Proposed Rules
presumption is not limited to the three
listed examples. See 75 FR 61995.
FGIDs are medically unexplained
chronic multisymptom illnesses within
the meaning of the statute and
regulation. These disorders are defined
by clusters of signs and symptoms
affecting GI functions. Further, FGIDs
are ‘‘medically unexplained’’ because
they are, by definition, disorders that
cannot be attributed to observable
structural or organic changes and the
causes of the disorders are generally not
known. Irritable Bowel Syndrome,
which is a form of FGID, is expressly
identified in the current statute and
regulation as a medically unexplained
chronic multisymptom illness. Because
other FGIDs, such as functional
dyspepsia and functional vomiting, also
are medically unexplained chronic
multisymptom illnesses, the current
statute and regulation, as recently
amended, provide a presumption of
service connection for FGIDs in veterans
who served in the Southwest Asia
theater of operations during the Persian
Gulf War. In view of the findings in the
recent NAS report identifying FGIDs as
prevalent and persistent illnesses among
Gulf War Veterans, VA has determined
that its regulations should be revised to
expressly identify FGIDs as a type of
medically unexplained chronic
multisymptom illness within the scope
of the existing presumption.
Regulatory Amendments
We propose to amend 38 CFR 3.317
to incorporate the more specific
language regarding FGIDs. We propose
to: Revise § 3.317(a)(2)(i)(B)(3) by
removing ‘‘Irritable Bowel Syndrome’’
and replacing it with ‘‘Functional
gastrointestinal disorders, including, but
not limited to, irritable bowel syndrome
and functional dyspepsia (excluding
structural gastrointestinal diseases)’’;
and add a Note with the definition of
functional gastrointestinal disorders.
The intended effect of this change is to
clarify that FGIDs are medically
unexplained chronic multisymptom
illnesses and are thus within the scope
of the presumption of service
connection for such illnesses.
erowe on DSK5CLS3C1PROD with PROPOSALS-1
Other Illnesses
This proposed rule does not reflect
determinations concerning any illnesses
other than those discussed in this
proposal. The Secretary’s
determinations concerning other
illnesses discussed in the NAS report
will be addressed in other documents
published in the Federal Register.
VerDate Mar<15>2010
15:18 Nov 16, 2010
Jkt 223001
Paperwork Reduction Act
This document contains no provisions
constituting a collection of information
under the Paperwork Reduction Act (44
U.S.C. 3501–3521).
Regulatory Flexibility Act
The Secretary hereby certifies that
this rule will not have a significant
economic impact on a substantial
number of small entities as they are
defined in the Regulatory Flexibility
Act, 5 U.S.C. 601–612. This rule would
not affect any small entities. Only VA
beneficiaries could be directly affected.
Therefore, pursuant to 5 U.S.C. 605(b),
this rule is exempt from the initial and
final regulatory flexibility analysis
requirements of §§ 603 and 604.
Executive Order 12866
Executive Order 12866 directs
agencies to assess all costs and benefits
of available regulatory alternatives and,
when regulation is necessary, to select
regulatory approaches that maximize
net benefits (including potential
economic, environmental, public health
and safety, and other advantages;
distributive impacts; and equity). The
Executive Order classifies a ‘‘significant
regulatory action,’’ requiring review by
the Office of Management and Budget
(OMB), as any regulatory action that is
likely to result in a rule that may: (1)
Have an annual effect on the economy
of $100 million or more or adversely
affect in a material way the economy, a
sector of the economy, productivity,
competition, jobs, the environment,
public health or safety, or State, local,
or tribal governments or communities;
(2) create a serious inconsistency or
otherwise interfere with an action taken
or planned by another agency; (3)
materially alter the budgetary impact of
entitlements, grants, user fees, or loan
programs or the rights and obligations of
recipients thereof; or (4) raise novel
legal or policy issues arising out of legal
mandates, the President’s priorities, or
the principles set forth in the Executive
Order.
The economic, interagency,
budgetary, legal, and policy
implications of this proposed rule have
been examined and it has been
determined not to be a significant
regulatory action under the Executive
Order because it would not result in a
rule that may materially alter the
budgetary impact of entitlements,
grants, user fees, or loan programs or the
rights and obligations of recipients
thereof.
Unfunded Mandates
The Unfunded Mandates Reform Act
of 1995 requires, at 2 U.S.C. 1532, that
PO 00000
Frm 00015
Fmt 4702
Sfmt 4702
agencies prepare an assessment of
anticipated costs and benefits before
issuing any rule that may result in the
expenditure by State, local, and tribal
governments, in the aggregate, or by the
private sector, of $100 million or more
(adjusted annually for inflation) in any
year. This rule would have no such
effect on State, local, and tribal
governments, or on the private sector.
Catalog of Federal Domestic Assistance
Numbers and Titles
The Catalog of Federal Domestic
Assistance program numbers and titles
for this proposed rule are 64.109,
Veterans Compensation for ServiceConnected Disability, and 64.110,
Veterans Dependency and Indemnity
Compensation for Service-Connected
Death.
Comment Period
Although under the rulemaking
guidelines in Executive Order 12866 VA
ordinarily provides a 60-day comment
period, the Secretary has determined
that there is good cause to limit the
public comment period on this
proposed rule to 30 days. The current
proposed rule does not create a new
presumption of service connection.
Consistent with 38 U.S.C. 1117, it
clarifies that functional gastrointestinal
disorders fall within the scope of the
existing presumption of service
connection for medically unexplained
chronic multisymptom illnesses.
Because this rule merely clarifies VA’s
interpretation of the existing statute and
regulation, a public comment period is
not required under the Administrative
Procedures Act. However, because this
clarifying rule relates to VA’s response
to a report referred to in 38 U.S.C. 1118,
VA has determined that it is appropriate
to provide for public comment as
provided in that statute. A 30-day notice
and comment period will enable the
rapid issuance of final regulations
providing the public and VA
adjudicators with clear guidance
regarding the interpretation of the
existing statute and regulation as they
pertain to FGIDs. This will ensure that
Veterans suffering from FGID will
receive a fair determination of benefit
eligibility, and will promote rapid
action on affected benefits claims.
Signing Authority
The Secretary of Veterans Affairs, or
designee, approved this document and
authorized the undersigned to sign and
submit the document to the Office of the
Federal Register for publication
electronically as an official document of
the Department of Veterans Affairs. John
R. Gingrich, Chief of Staff, Department
E:\FR\FM\17NOP1.SGM
17NOP1
Federal Register / Vol. 75, No. 221 / Wednesday, November 17, 2010 / Proposed Rules
of Veterans Affairs, approved this
document on October 18, 2010, for
publication.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
List of Subjects in 38 CFR Part 3
Centers for Medicare & Medicaid
Services
Administrative practice and
procedure, Claims, Disability benefits,
Health care, Veterans, Vietnam.
42 CFR Chapter IV
Dated: November 9, 2010.
Robert C. McFetridge,
Director, Regulations Policy and
Management, Department of Veterans Affairs.
For the reasons set out in the
preamble, VA proposes to amend 38
CFR part 3 as follows:
■
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Request for information.
1. The authority citation for part 3,
subpart A continues to read as follows:
Authority: 38 U.S.C. 501(a), unless
otherwise noted.
2. Amend § 3.317 by revising
paragraph (a)(2)(i)(B)(3) to read as
follows:
erowe on DSK5CLS3C1PROD with PROPOSALS-1
§ 3.317 Compensation for certain
disabilities due to undiagnosed illnesses.
(a) * * *
(2) * * *
(i) * * *
(B) * * *
(3) Functional gastrointestinal
disorders, including, but not limited to,
irritable bowel syndrome and functional
dyspepsia (excluding structural
gastrointestinal diseases); or Note to
paragraph (a)(2)(i)(B)(3): Functional
gastrointestinal disorders are a group of
conditions characterized by chronic or
recurrent symptoms that were present
for at least 6 months prior to diagnosis
and have been currently active for 3
months, that are unexplained by any
structural, endoscopic, laboratory, or
other objective signs of disease or injury
and that may be related to any part of
the gastrointestinal tract. Common
symptoms include abdominal pain,
substernal burning or pain, nausea,
vomiting, altered bowel habits
(including diarrhea, constipation),
indigestion, bloating, postprandial
fullness, and painful or difficult
swallowing. Specific functional
gastrointestinal disorders include, but
are not limited to, irritable bowel
syndrome, functional dyspepsia,
functional vomiting, functional
constipation, functional bloating,
functional abdominal pain syndrome,
and functional dysphagia.
VerDate Mar<15>2010
15:18 Nov 16, 2010
Jkt 223001
This document is a request for
comments regarding certain aspects of
the policies and standards that will
apply to accountable care organizations
(ACOs) participating in the Medicare
program under section 3021 or 3022 of
the Affordable Care Act.
DATES: Comment Date: To be assured
consideration, comments must be
received at one of the addresses
provided below, no later than 5 p.m. on
December 3, 2010.
ADDRESSES: In commenting, please refer
to file code CMS–1345–NC. Because of
staff and resource limitations, we cannot
accept comments by facsimile (FAX)
transmission.
You may submit comments in one of
four ways (please choose only one of the
ways listed):
• Electronically. You may submit
electronic comments on this regulation
to https://www.regulations.gov. Follow
‘‘Submit a comment’’ instructions.
• By regular mail. You may mail
written comments to the following
address ONLY: Centers for Medicare &
Medicaid Services, Department of
Health and Human Services, Attention:
CMS–1345–NC, P.O. Box 8013,
Baltimore, MD 21244–8013.
Please allow sufficient time for mailed
comments to be received before the
close of the comment period.
• By express or overnight mail. You
may send written comments to the
following address ONLY: Centers for
Medicare & Medicaid Services,
Department of Health and Human
Services, Attention: CMS–1345–NC,
Mail Stop C4–26–05, 7500 Security
Boulevard, Baltimore, MD 21244–1850.
• By hand or courier. Alternatively,
you may deliver (by hand or courier)
your written comments ONLY to one of
the following addresses prior to the
close of the comment period:
a. For delivery in Washington, DC—
Centers for Medicare & Medicaid
Services, Department of Health and
SUMMARY:
Subpart A—Pension, Compensation,
and Dependency and Indemnity
Compensation
BILLING CODE 8320–01–P
Medicare Program; Request for
Information Regarding Accountable
Care Organizations and the Medicare
Shared Saving Program
AGENCY:
PART 3—ADJUDICATION
[FR Doc. 2010–28707 Filed 11–16–10; 8:45 am]
[CMS–1345–NC]
PO 00000
Frm 00016
Fmt 4702
Sfmt 4702
70165
Human Services, Room 445–G, Hubert
H. Humphrey Building, 200
Independence Avenue, SW.,
Washington, DC 20201.
(Because access to the interior of the
Hubert H. Humphrey Building is not
readily available to persons without
Federal government identification,
commenters are encouraged to leave
their comments in the CMS drop slots
located in the main lobby of the
building. A stamp-in clock is available
for persons wishing to retain a proof of
filing by stamping in and retaining an
extra copy of the comments being filed.)
b. For delivery in Baltimore, MD—
Centers for Medicare & Medicaid
Services, Department of Health and
Human Services, 7500 Security
Boulevard, Baltimore, MD 21244–1850.
If you intend to deliver your
comments to the Baltimore address, call
telephone number (410) 786–7195 in
advance to schedule your arrival with
one of our staff members.
Comments erroneously mailed to the
addresses indicated as appropriate for
hand or courier delivery may be delayed
and received after the comment period.
FOR FURTHER INFORMATION CONTACT:
Thomas Carey, (410) 786–4560 or
Thomas.Carey@cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
Inspection of Public Comments: All
comments received before the close of
the comment period are available for
viewing by the public, including any
personally identifiable or confidential
business information that is included in
a comment. We post all comments
received before the close of the
comment period on the following Web
site as soon as possible after they have
been received: https://
www.regulations.gov. Follow the search
instructions on that Web site to view
public comments.
Comments received timely will also
be available for public inspection as
they are received, generally beginning
approximately 3 weeks after publication
of a document, at the headquarters of
the Centers for Medicare & Medicaid
Services, 7500 Security Boulevard,
Baltimore, Maryland 21244, Monday
through Friday of each week from
8:30 a.m. to 4 p.m. To schedule an
appointment to view public comments,
phone 1–800–743–3951.
I. Background
The Affordable Care Act seeks to
improve the quality of health care
services and to lower health care costs
by encouraging providers to create
integrated health care delivery systems.
These integrated systems will test new
reimbursement methods intended to
E:\FR\FM\17NOP1.SGM
17NOP1
Agencies
[Federal Register Volume 75, Number 221 (Wednesday, November 17, 2010)]
[Proposed Rules]
[Pages 70162-70165]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-28707]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
38 CFR Part 3
RIN 2900-AN83
Presumptive Service Connection for Diseases Associated With
Persian Gulf War Service: Functional Gastrointestinal Disorders
AGENCY: Department of Veterans Affairs.
ACTION: Proposed rule.
-----------------------------------------------------------------------
SUMMARY: The Department of Veterans Affairs (VA) is amending its
adjudication regulations concerning presumptive service connection for
medically unexplained chronic multisymptom illnesses associated with
service in the Southwest Asia theater of operations for which there is
no record during service. This amendment is necessary to implement a
decision of the Secretary of Veterans Affairs that there is a positive
association between service in Southwest Asia during certain periods
and the subsequent development of functional gastrointestinal disorders
(FGIDs), and to clarify that FGIDs fall within the scope of the
existing presumption of service connection for medically
[[Page 70163]]
unexplained chronic multisymptom illnesses. The intended effect of this
amendment is to clarify the presumption of service connection for these
illnesses based on service in the Southwest Asia theater of operations
during the Persian Gulf War.
DATES: Comments must be received by VA on or before December 17, 2010.
ADDRESSES: Written comments may be submitted through https://www.Regulations.gov; by mail or hand-delivery to Director, Regulations
Management (02REG), Department of Veterans Affairs, 810 Vermont Ave.,
NW., Room 1068, Washington, DC 20420; or by fax to (202) 273-9026.
(This is not a toll free number.) Comments should indicate that they
are submitted in response to ``RIN 2900-AN83--Presumptive Service
Connection for Diseases Associated With Persian Gulf War Service:
Functional Gastrointestinal Disorders (FGIDs).''
Copies of comments received will be available for public inspection
in the Office of Regulation Policy and Management, Room 1063B, between
the hours of 8 a.m. and 4:30 p.m., Monday through Friday (except
holidays). Please call (202) 461-4902 for an appointment. (This is not
a toll free number.) In addition, during the comment period, comments
may be viewed online through the Federal Docket Management System at
https://www.Regulations.gov.
FOR FURTHER INFORMATION CONTACT: Gerald Johnson, Regulations Staff
(211D), Compensation and Pension Service, Veterans Benefits
Administration, Department of Veterans Affairs, 810 Vermont Avenue,
NW., Washington, DC 20420, (202) 461- 9727 (This is not a toll-free
number.)
SUPPLEMENTARY INFORMATION: The Secretary of Veterans Affairs has
determined that the available scientific and medical evidence presented
in the National Academy of Sciences (NAS) April 2010 report, titled
Gulf War and Health, Volume 8: Update on the Health Effects of Serving
in the Gulf War is sufficient to warrant a presumption of service
connection for FGIDs in individuals deployed to the Southwest Asia
theater of operations during the Persian Gulf War. Pursuant to that
determination, this document proposes to clarify that the Department of
Veterans Affairs (VA) adjudication regulations (38 CFR Part 3),
specifically 38 CFR 3.317, would include FGIDs as medically unexplained
chronic multisymptom illnesses subject to presumptive service
connection. FGIDs include, but are not limited to, such conditions as
irritable bowel syndrome (IBS) and functional dyspepsia.
National Academy of Sciences (NAS) Reports
FGIDs, Including, But Not Limited to, Irritable Bowel Syndrome (IBS)
and Functional Dyspepsia
The NAS issued its report titled Gulf War and Health, Volume 8:
Update on Health Effects of Serving in the Gulf War, on April 9, 2010.
The NAS was asked to review, evaluate, and summarize the literature to
determine if any of the health outcomes noted in its 2006 report,
titled Gulf War and Health, Volume 4: Health Effects of Serving in the
Gulf War, appear at higher incidence or prevalence levels in Gulf War-
deployed veterans. The NAS sought to characterize and weigh the
strengths and limitations of the available evidence. The NAS Update
committee reviewed over 1000 relevant studies and focused on over 400
relevant references, including the studies reviewed in the Volume 4
report. The NAS determined that there is sufficient evidence of an
association between deployment to the Gulf War and FGIDs, including,
but not limited to, IBS and functional dyspepsia. The committee also
noted that there is inadequate evidence of an association between
deployment to the Gulf War and structural gastrointestinal (GI)
disease.
FGIDs, such as IBS or functional dyspepsia, are syndromes
characterized by recurrent or prolonged GI symptoms that occur
together. They are distinguished from structural or ``organic'' GI
disorders in that they generally are not associated with detectable
anatomical abnormalities. The severity of FGIDs ranges from occasional
mild episodes to more persistent and disabling symptoms. According to
the NAS report, there have been numerous reports of GI disturbances in
Gulf War veterans and the symptoms have continued to be persistent in
the years since that war. All studies examined by NAS favored a greater
prevalence of various GI symptoms and primary functional GI disorders,
including IBS and dyspepsia. In NAS's opinion, there also was
compelling emerging evidence of exposure during deployment to enteric
pathogens leading to the development of post-infectious IBS.
The overall pattern of symptoms found in the primary and secondary
studies NAS reviewed confirms an association between deployment to the
Gulf War and functional GI symptoms, including abdominal pain,
diarrhea, nausea, and vomiting. The NAS recommended that further
studies be conducted to determine the role of prior acute
gastroenteritis among deployed servicemembers in the development of
FGIDs.
Detailed information on the committee's findings may be found at:
https://www.iom.edu/Reports/2010/Gulf-War-and-Health-Volume-8-Health-Effects-of-Serving-in-the-Gulf-War.aspx. The report findings are
organized by category and can be found under the heading, ``Table of
Contents.''
Statutory Provisions
Pursuant to 38 U.S.C. 1118, VA must establish a presumption of
service connection for each illness shown by sound scientific and
medical evidence to have a positive association with exposure to a
biological, chemical, or other toxic agent, environmental or wartime
hazard, or preventive medicine or vaccine known or presumed to be
associated with service in the Armed Forces in the Southwest Asia
theater of operations during the Persian Gulf War. Because the recent
NAS report was primarily a review of the prevalence of illnesses among
Gulf War veterans, it generally did not state conclusions as to whether
the illnesses are associated with the types of exposures referenced in
Sec. 1118. The NAS noted that there was significant emerging evidence
that FGIDs may be associated with exposure to enteric pathogens during
Gulf War deployments and recommended further study of that issue.
However, NAS did not state a conclusion concerning the strength of the
evidence of an association between FGIDs and exposure to enteric
pathogens. VA has determined that resolution of that question is not
necessary for purposes of this rule, because FGIDs are within the scope
of the existing presumption of service connection for medically
unexplained chronic multisymptom illnesses.
Section 1117 of title 38, United States Code, provides a
presumption of service connection for ``qualifying chronic disability''
in veterans who served in the Southwest Asia theater of operations
during the Persian Gulf War. The statute defines the term ``qualifying
chronic disability'' to include ``[a] medically unexplained chronic
multisymptom illness (such as chronic fatigue syndrome, fibromyalgia,
and irritable bowel syndrome) that is defined by a cluster of signs or
symptoms.'' 38 U.S.C. 1117(a)(2)(B). The plain language of the statute
makes clear that it applies to all medically unexplained chronic
multisymptom illnesses including, but not limited to, the three
conditions parenthetically listed as examples. VA recently amended its
regulation at 38 CFR 3.317 to clarify that the
[[Page 70164]]
presumption is not limited to the three listed examples. See 75 FR
61995.
FGIDs are medically unexplained chronic multisymptom illnesses
within the meaning of the statute and regulation. These disorders are
defined by clusters of signs and symptoms affecting GI functions.
Further, FGIDs are ``medically unexplained'' because they are, by
definition, disorders that cannot be attributed to observable
structural or organic changes and the causes of the disorders are
generally not known. Irritable Bowel Syndrome, which is a form of FGID,
is expressly identified in the current statute and regulation as a
medically unexplained chronic multisymptom illness. Because other
FGIDs, such as functional dyspepsia and functional vomiting, also are
medically unexplained chronic multisymptom illnesses, the current
statute and regulation, as recently amended, provide a presumption of
service connection for FGIDs in veterans who served in the Southwest
Asia theater of operations during the Persian Gulf War. In view of the
findings in the recent NAS report identifying FGIDs as prevalent and
persistent illnesses among Gulf War Veterans, VA has determined that
its regulations should be revised to expressly identify FGIDs as a type
of medically unexplained chronic multisymptom illness within the scope
of the existing presumption.
Regulatory Amendments
We propose to amend 38 CFR 3.317 to incorporate the more specific
language regarding FGIDs. We propose to: Revise Sec.
3.317(a)(2)(i)(B)(3) by removing ``Irritable Bowel Syndrome'' and
replacing it with ``Functional gastrointestinal disorders, including,
but not limited to, irritable bowel syndrome and functional dyspepsia
(excluding structural gastrointestinal diseases)''; and add a Note with
the definition of functional gastrointestinal disorders. The intended
effect of this change is to clarify that FGIDs are medically
unexplained chronic multisymptom illnesses and are thus within the
scope of the presumption of service connection for such illnesses.
Other Illnesses
This proposed rule does not reflect determinations concerning any
illnesses other than those discussed in this proposal. The Secretary's
determinations concerning other illnesses discussed in the NAS report
will be addressed in other documents published in the Federal Register.
Paperwork Reduction Act
This document contains no provisions constituting a collection of
information under the Paperwork Reduction Act (44 U.S.C. 3501-3521).
Regulatory Flexibility Act
The Secretary hereby certifies that this rule will not have a
significant economic impact on a substantial number of small entities
as they are defined in the Regulatory Flexibility Act, 5 U.S.C. 601-
612. This rule would not affect any small entities. Only VA
beneficiaries could be directly affected. Therefore, pursuant to 5
U.S.C. 605(b), this rule is exempt from the initial and final
regulatory flexibility analysis requirements of Sec. Sec. 603 and 604.
Executive Order 12866
Executive Order 12866 directs agencies to assess all costs and
benefits of available regulatory alternatives and, when regulation is
necessary, to select regulatory approaches that maximize net benefits
(including potential economic, environmental, public health and safety,
and other advantages; distributive impacts; and equity). The Executive
Order classifies a ``significant regulatory action,'' requiring review
by the Office of Management and Budget (OMB), as any regulatory action
that is likely to result in a rule that may: (1) Have an annual effect
on the economy of $100 million or more or adversely affect in a
material way the economy, a sector of the economy, productivity,
competition, jobs, the environment, public health or safety, or State,
local, or tribal governments or communities; (2) create a serious
inconsistency or otherwise interfere with an action taken or planned by
another agency; (3) materially alter the budgetary impact of
entitlements, grants, user fees, or loan programs or the rights and
obligations of recipients thereof; or (4) raise novel legal or policy
issues arising out of legal mandates, the President's priorities, or
the principles set forth in the Executive Order.
The economic, interagency, budgetary, legal, and policy
implications of this proposed rule have been examined and it has been
determined not to be a significant regulatory action under the
Executive Order because it would not result in a rule that may
materially alter the budgetary impact of entitlements, grants, user
fees, or loan programs or the rights and obligations of recipients
thereof.
Unfunded Mandates
The Unfunded Mandates Reform Act of 1995 requires, at 2 U.S.C.
1532, that agencies prepare an assessment of anticipated costs and
benefits before issuing any rule that may result in the expenditure by
State, local, and tribal governments, in the aggregate, or by the
private sector, of $100 million or more (adjusted annually for
inflation) in any year. This rule would have no such effect on State,
local, and tribal governments, or on the private sector.
Catalog of Federal Domestic Assistance Numbers and Titles
The Catalog of Federal Domestic Assistance program numbers and
titles for this proposed rule are 64.109, Veterans Compensation for
Service-Connected Disability, and 64.110, Veterans Dependency and
Indemnity Compensation for Service-Connected Death.
Comment Period
Although under the rulemaking guidelines in Executive Order 12866
VA ordinarily provides a 60-day comment period, the Secretary has
determined that there is good cause to limit the public comment period
on this proposed rule to 30 days. The current proposed rule does not
create a new presumption of service connection. Consistent with 38
U.S.C. 1117, it clarifies that functional gastrointestinal disorders
fall within the scope of the existing presumption of service connection
for medically unexplained chronic multisymptom illnesses. Because this
rule merely clarifies VA's interpretation of the existing statute and
regulation, a public comment period is not required under the
Administrative Procedures Act. However, because this clarifying rule
relates to VA's response to a report referred to in 38 U.S.C. 1118, VA
has determined that it is appropriate to provide for public comment as
provided in that statute. A 30-day notice and comment period will
enable the rapid issuance of final regulations providing the public and
VA adjudicators with clear guidance regarding the interpretation of the
existing statute and regulation as they pertain to FGIDs. This will
ensure that Veterans suffering from FGID will receive a fair
determination of benefit eligibility, and will promote rapid action on
affected benefits claims.
Signing Authority
The Secretary of Veterans Affairs, or designee, approved this
document and authorized the undersigned to sign and submit the document
to the Office of the Federal Register for publication electronically as
an official document of the Department of Veterans Affairs. John R.
Gingrich, Chief of Staff, Department
[[Page 70165]]
of Veterans Affairs, approved this document on October 18, 2010, for
publication.
List of Subjects in 38 CFR Part 3
Administrative practice and procedure, Claims, Disability benefits,
Health care, Veterans, Vietnam.
Dated: November 9, 2010.
Robert C. McFetridge,
Director, Regulations Policy and Management, Department of Veterans
Affairs.
0
For the reasons set out in the preamble, VA proposes to amend 38 CFR
part 3 as follows:
PART 3--ADJUDICATION
Subpart A--Pension, Compensation, and Dependency and Indemnity
Compensation
1. The authority citation for part 3, subpart A continues to read
as follows:
Authority: 38 U.S.C. 501(a), unless otherwise noted.
2. Amend Sec. 3.317 by revising paragraph (a)(2)(i)(B)(3) to read
as follows:
Sec. 3.317 Compensation for certain disabilities due to undiagnosed
illnesses.
(a) * * *
(2) * * *
(i) * * *
(B) * * *
(3) Functional gastrointestinal disorders, including, but not
limited to, irritable bowel syndrome and functional dyspepsia
(excluding structural gastrointestinal diseases); or Note to paragraph
(a)(2)(i)(B)(3): Functional gastrointestinal disorders are a group of
conditions characterized by chronic or recurrent symptoms that were
present for at least 6 months prior to diagnosis and have been
currently active for 3 months, that are unexplained by any structural,
endoscopic, laboratory, or other objective signs of disease or injury
and that may be related to any part of the gastrointestinal tract.
Common symptoms include abdominal pain, substernal burning or pain,
nausea, vomiting, altered bowel habits (including diarrhea,
constipation), indigestion, bloating, postprandial fullness, and
painful or difficult swallowing. Specific functional gastrointestinal
disorders include, but are not limited to, irritable bowel syndrome,
functional dyspepsia, functional vomiting, functional constipation,
functional bloating, functional abdominal pain syndrome, and functional
dysphagia.
[FR Doc. 2010-28707 Filed 11-16-10; 8:45 am]
BILLING CODE 8320-01-P